Sunset Acquires Two Skincare Products
RoEzIt Dermal Care and CPAP Moisture Therapy are designed to help increase patient comfort and compliance with oxygen and sleep therapy.
HME manufacturer and distributor Sunset Healthcare Solutions has acquired two new skincare products: RoEzIt Dermal Care and CPAP Moisture Therapy from Texas-based brand Lousal Enterprises Inc.
Both products aim to increase patient comfort in order to help foster increased comfort. RoEzIt Dermal Care is primarily designed to combat the side effects of oxygen therapy and CPAP Moisture Therapy is designed to address the side effects of CPAP therapy. The patented formulas for both are petroleum-free.
Both oxygen and CPAP therapies can cause extreme nasal dryness and irritation that can become painful due to the continuous flow of air going through and around the nasal passages.
With oxygen treatment, patients may experience tissue irritation from the nasal prongs rubbing against the inside of the nose. With CPAP treatment, patients may report skin irritation and skin breakdown caused by nasal pillows or masks rubbing against the skin. Caregivers report that patients who develop these side effects decrease their compliance rates, according to Sunset.
The products are an ideal fit for the healthcare company, said PJ Ruflin, vice president of business development for Sunset.
“Sunset was a successful reseller of these products for years, and when they were no longer available, it quickly became apparent that the market and patient base really missed them,” Ruflin explained. “Sunset is invested in supporting the DME community through great products and service and thereby benefiting the patients our DME community serves. These products are right in line with that, as they provide clinical benefit to patients, drive compliance with therapy, and provide a great cash sale opportunity for the DME.”
